Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Alembic Pharma gets USFDA nod for Bromfenac Ophthalmic Solution

      Alembic Pharma gets USFDA nod for Bromfenac Ophthalmic Solution

      Farhat Nasim24 Jun 2019 12:25 PM IST
      The approved product, Bromfenac Ophthalmic Solution is therapeutically equivalent to the reference listed drug (RLD), Bromday Ophthalmic Solution,...
      Dr Reddys gets two USFDA observations for Vizag plants

      Dr Reddys gets two USFDA observations for Vizag plants

      Farhat Nasim24 Jun 2019 11:09 AM IST
      Hyderabad: City-based Dr Reddy's Laboratories (Dr Reddys/ DRL) has reportedly fallen under the US health regulator's scanner. The company has been...
      USFDA declines to approve Daiichi Sankyo blood cancer treatment Quizartinib

      USFDA declines to approve Daiichi Sankyo blood cancer treatment Quizartinib

      Farhat Nasim23 Jun 2019 10:00 AM IST
      The decision follows an advisory committee meeting, held in May, where independent advisers to the U.S. regulator voted 8-3 against the drug's...
      AstraZeneca, NCCN collaborate to improve outcomes in Ovarian Cancer

      AstraZeneca, NCCN collaborate to improve outcomes in Ovarian Cancer

      Farhat Nasim23 Jun 2019 9:00 AM IST
      New Delhi: The National Comprehensive Cancer Network (NCCN) Oncology Research Program (ORP) is collaborating with AstraZeneca, a global, science-led...
      GSK offers concessions to address Pfizer deal concerns

      GSK offers concessions to address Pfizer deal concerns

      Farhat Nasim23 Jun 2019 8:59 AM IST
      GSK announced the deal in December last year, a move which will put it ahead of rivals Johnson & Johnson, Bayer and Sanofi.BRUSSELS:...
      Price of 1000 plus essential medicines capped by Government: Ministers inform Parliament

      Price of 1000 plus essential medicines capped by Government: Ministers inform Parliament

      Farhat Nasim22 Jun 2019 3:13 PM IST
      The parliament was also apprised about the details of drugs under the list of Essential Medicines, as included in the National List of Essential...
      Radiant Life acquires 49.7 pc stake in Max Healthcare to make third largest hospital chain in India

      Radiant Life acquires 49.7 pc stake in Max Healthcare to make third largest hospital chain in India

      Farhat Nasim22 Jun 2019 11:06 AM IST
      Radiant Life Care promoter Abhay Soi will now lead Max Healthcare as chairman of its board and executive council, the companies said in a joint...
      USFDA okays female Viagra for treating hypoactive sexual desire disorder in premenopausal women

      USFDA okays female Viagra for treating hypoactive sexual desire disorder in premenopausal women

      Farhat Nasim22 Jun 2019 9:35 AM IST
      Vyleesi is only the second approved to increase sexual desire in a woman, a market drugmakers have been trying to cultivate since the blockbuster...
      MPI beings supplying animal tissue to SCTIMST, medical device industry for making heart valve, wound care patches

      MPI beings supplying animal tissue to SCTIMST, medical device industry for making heart valve, wound care patches

      Farhat Nasim22 Jun 2019 9:30 AM IST
      Through this venture, the Kochi-based MPI would be supported by SCTIMST to attain this unique status, thereby aiding in the development of affordable...
      Fortis Healthcare appoints Sanjay Sinha as Chief of Human Resources Officer

      Fortis Healthcare appoints Sanjay Sinha as Chief of Human Resources Officer

      Farhat Nasim22 Jun 2019 9:24 AM IST
      Sanjay Sinha will lead the Human Resource (HR) function at a group level based out of the Corporate Office of Fortis in Gurugram, Haryana. New Delhi:...
      India to step up pharmaceutical exports; calls for clear roadmap from China

      India to step up pharmaceutical exports; calls for clear roadmap from China

      Farhat Nasim22 Jun 2019 9:06 AM IST
      Besides pharmaceutical(s), India has been asking China to open up its IT market as well to ensure a steady increase of Indian exports.BEIJING: India...
      Sun Pharma not following procedures to prevent contamination of drug products; USFDA flags concern

      Sun Pharma not following procedures to prevent contamination of drug products; USFDA flags concern

      Farhat Nasim21 Jun 2019 4:42 PM IST
      New Delhi: In a major setback, country’s drug giant Sun Pharmaceutical Industries (Sun Pharma) is reported to have received four observations from the...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok